Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-26-316771
Filing Date
2026-07-27
Accepted
2026-07-27 06:10:02
Documents
6
Period of Report
2026-07-27

Document Format Files

Seq Description Document Type Size
1 6-K d150377d6k.htm 6-K 8519
2 EX-99.1 d150377dex991.htm EX-99.1 20531
3 EX-99.2 d150377dex992.htm EX-99.2 15494
4 GRAPHIC g150377g0725022852296.jpg GRAPHIC 3282
5 GRAPHIC g150377g0725023152932.jpg GRAPHIC 3449
6 GRAPHIC g150377g13s50.jpg GRAPHIC 2139
  Complete submission text file 0001193125-26-316771.txt   58427
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 261202760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)